New drug shows promise for rare, severe psoriasis
NCT ID NCT06323356
First seen Oct 31, 2025 · Last updated May 16, 2026 · Updated 26 times
Summary
This study tests whether TAK-279 can improve symptoms of two rare and severe forms of psoriasis: generalized pustular psoriasis and erythrodermic psoriasis. About 18 adults will receive the drug for up to 52 weeks. The main goal is to see if their skin becomes clear or almost clear by week 16.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED PUSTULAR PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fujita Health University Hospital
Toyoake, Aichi-ken, Japan
-
Fukuoka University Hospital
Fukuoka, Japan
-
Hospital of the University of Occupational and Environmental Health, Japan
Kitakyushu, Fukuoka, Japan
-
Isesaki Municipal Hospital
Isesaki, Gunma, Japan
-
Juntendo University Urayasu Hospital
Urayasu, Chiba, Japan
-
Kansai Medical University Hospital
Hirakata, Osaka, Japan
-
Kimitsu Chuo Hospital
Kisarazu, Chiba, Japan
-
Kobe University Hospital
Kobe, Hyōgo, Japan
-
Mie University Hospital
Tsu, Mie-ken, Japan
-
Nagoya City University Hospital
Nagoya, Aichi-ken, Japan
-
Nippon Life Hospital
Osaka, Japan
-
Okayama University Hospital
Okayama, Japan
-
Osaka Metropolitan University Hospital
Osaka, Japan
-
Saitama Medical University Hospital
Iruma, Saitama, Japan
-
St.Luke's International Hospital
Chūō, Tokyo, Japan
-
Teikyo University Hospital
Itabashi-ku, Tokyo, Japan
-
The Jikei University Hospital
Minato-ku, Tokyo, Japan
-
Tokai University Hospital
Isehara, Kanagawa, Japan
-
Tokyo Medical University Hospital
Shinjuku-ku, Tokyo, Japan
-
University Hospital, Kyoto Prefectural University of Medicine
Kyoto, Japan
Conditions
Explore the condition pages connected to this study.